Forced expiratory volume in 1 second (FEV1)

/Tag:Forced expiratory volume in 1 second (FEV1)

EFFICACY AND SAFETY OF REVEFENACIN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS NOT AGE DEPENDENT: A POST HOC SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS

Background: Revefenacin (REV), a once-daily, long-acting muscarinic antagonist for nebulized inhalation, was recently approved for maintenance treatment of chronic obstructive pulmonary disease (COPD). We present post hoc efficacy and safety data from three phase 3 [...]

By | 2019-03-11T14:18:44+00:00 March 11th, 2019|Hospital Medicine 2019, Other, Research|Comments Off on EFFICACY AND SAFETY OF REVEFENACIN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS NOT AGE DEPENDENT: A POST HOC SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS